{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:47:52Z","timestamp":1760906872878},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"S11","license":[{"start":{"date-parts":[[1985,11,1]],"date-time":"1985-11-01T00:00:00Z","timestamp":499651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1985,11]]},"DOI":"10.1007\/bf01309404","type":"journal-article","created":{"date-parts":[[2005,3,25]],"date-time":"2005-03-25T23:12:29Z","timestamp":1111792349000},"page":"164S-170S","source":"Crossref","is-referenced-by-count":53,"title":["Healing of benign gastric ulcer"],"prefix":"10.1007","volume":"30","author":[{"given":"N. M.","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Saffouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. M.","family":"Kruss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A.","family":"Callison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Z.","family":"Dajani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","unstructured":"Kurata JH: Time trends.In MI Grossman (moderator). Peptic Ulcer: New Therapies, New Diseases. Ann Intern Med 95:609?610, 1981","DOI":"10.7326\/0003-4819-95-5-609"},{"key":"CR2","volume-title":"Gastrointestinal Disease","author":"CT Richardson","year":"1978","unstructured":"Richardson CT: Gastric ulcer.In MH Sleisenger, JS Fordtran (eds). Gastrointestinal Disease, Ed 2, Philadelphia, W.B. Saunders, 1978, Chap 51","edition":"Ed 2"},{"issue":"3","key":"CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0011-5029(81)80001-6","volume":"28","author":"JI Isenberg","year":"1981","unstructured":"Isenberg JI: Peptic ulcer: Dis Month 28(3):1?58, 1981","journal-title":"Dis Month"},{"issue":"Suppl 2","key":"CR4","first-page":"95","volume":"3","author":"GL Kauffman","year":"1981","unstructured":"Kauffman GL: Drug therapy for peptic ulcer: Drugs that act on the gastric mucosa. J. Clin Gastroenterol 3(Suppl 2): 95?101, 1981","journal-title":"J. Clin Gastroenterol"},{"key":"CR5","unstructured":"Robert A: Prostaglandins and the concept of cytoprotection.In MI Grossman (moderator). Peptic Ulcer: New Therapies, New Diseases. Ann Intern Med 95:616?618, 1981"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0016-5085(76)80147-3","volume":"70","author":"A Robert","year":"1976","unstructured":"Robert A, Schultz JR, Nezamis JE, Lancaster C: Gastric antisecretory and anti-ulcer properties of PGE2, 15 methyl PGE2 and 16,16-dimethyl PGE2. Intravenous, oral and intrajejunal administration. Gastroenterology 70:359?370, 1976","journal-title":"Gastroenterology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/BF01071862","volume":"21","author":"EZ Dajani","year":"1976","unstructured":"Dajani EZ, Driskill DR, Bianchi RG, Collins PW, Pappo R: SC-29333, A potent inhibitor of canine gastric secretion. Dig Dis Sci 21:1049?1057, 1976","journal-title":"Dig Dis Sci"},{"key":"CR8","first-page":"86","volume":"236","author":"DG Colton","year":"1978","unstructured":"Colton DG, Driskill DR, Phillips EL, Poy P, Dajani EZ: Effect of SC-29333, an inhibitor of gastric secretion, on canine gastric mucosal blood flow and serum gastrin levels. Arch Int Pharmacodyn Ther 236:86?95, 1978","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"CR9","first-page":"121","volume":"23","author":"RG Bianchi","year":"1981","unstructured":"Bianchi RG, Casler JJ, Dajani EZ: Gastric antisecretory and anti-ulcer activity of SC-29333, a synthetic E-prostaglandin analog. Pharmacologist 23:121 (Abstract), 1981","journal-title":"Pharmacologist"},{"key":"CR10","first-page":"1127","volume":"84","author":"MM Cohen","year":"1983","unstructured":"Cohen MM, Clark L, Armstrong L, D'Souza J: Reduced aspirin-induced fecal blood loss with simultaneous administration of misoprostol (PGE1 methyl analogue), Gastroenterology 84:1127 (Abstract), 1983","journal-title":"Gastroenterology"},{"issue":"10","key":"CR11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/BF01317040","volume":"28","author":"JN Hunt","year":"1983","unstructured":"Hunt JN, Smith JL, Jiang CL, Kessler L: Effect of synthetic prostaglandin E1 analog on aspirin-induced gastric bleeding and secretion. Dig Dis Sci 28(10):897?902, 1983","journal-title":"Dig Dis Sci"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF01072927","volume":"23","author":"EZ Dajani","year":"1978","unstructured":"Dajani EZ, Callison DA, Bertermann RE: Effects of Eprostaglandins on canine gastric potential difference. Dig Dis Sci 23:436?442, 1978","journal-title":"Dig Dis Sci"},{"key":"CR13","first-page":"283","volume":"210","author":"DG Colton","year":"1979","unstructured":"Colton DG, Callison DA, Dajani EZ: Effects of a prostaglandin E1 derivative, SC-29333, and aspirin on gastric ionic fluxes and potential difference in dogs. J Pharmacol Exp Ther 210:283?288, 1979","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl.","key":"CR14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0090-6980(81)90127-1","volume":"21","author":"KR Larsen","year":"1981","unstructured":"Larsen KR, Jensen NF, David EK, Jensen JC, Moody FG: The cytoprotective effects of (\u00b1) deoxy-16-alpha, betahydroxy-16-methyl PGE1, methyl ester (SC-29333) versus aspirin-shock gastric ulcerogenesis in the dog. Prostaglandins 21(Suppl.):119?124, 1981","journal-title":"Prostaglandins"},{"key":"CR15","first-page":"121","volume":"21","author":"L Kessler","year":"1981","unstructured":"Kessler L, Bianchi RG, Callison DA, Dajani EZ: Prevention of duodenal ulcer formation in cat by E-prostaglandins. Pharmacologist 21:121 (Abstract), 1981","journal-title":"Pharmacologist"},{"key":"CR16","series-title":"P4F Procedure","first-page":"143","volume-title":"BMDP Statistical Software 1982","author":"WJ Dixon","year":"1981","unstructured":"Dixon WJ: BMDP Statistical Software 1982. Berkeley, California: University of California Press. P4F Procedure 143?206, 1981"},{"issue":"1","key":"CR17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2307\/2346517","volume":"25","author":"MB Brown","year":"1976","unstructured":"Brown MB: Screening effects of multidimensional contingency tables. Appl Statistics 25(1):37?46, 1976","journal-title":"Appl Statistics"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5694\/j.1326-5377.1977.tb130638.x","volume":"1","author":"RRH Lovell","year":"1977","unstructured":"Lovell RRH: Problems of interpretation in secondary prevention trials in coronary heart disease. Med J Aust 1:224?226, 1977","journal-title":"Med J Aust"},{"key":"CR19","first-page":"52","volume-title":"Analysing Qualitative Data","author":"AE Maxwell","year":"1961","unstructured":"Maxwell AE: Analysing Qualitative Data. London: Methuen & Co Ltd, 1961, pp 52?62"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJM198306023082203","volume":"308","author":"JI Isenberg","year":"1983","unstructured":"Isenberg JI, Peterson WL, Elashoff JD, Sandeersfield MA, Reedy TJ, Ippoliti AF, Van Deventer GM, Frank H, Longstreth GF, Anderson DS: Healing of benign gastric ulcer with low dose antacid or cimetidine, A double-blind placebo controlled trial. New Engl J Med 308:1319?1324, 1983","journal-title":"New Engl J Med"},{"key":"CR21","first-page":"1098","volume":"80","author":"K Akdamar","year":"1981","unstructured":"Akdamar K, Dyck W, Englert E, Belsito A, Sontag S, Vlahcevic Z, Strickland R, Achord J, Graham D, Kornfield R, Agrawal N: Cimetidine versus placebo in the treatment of benign gastric ulcer. Gastroenterology 80:1098, (Abstract) 1981","journal-title":"Gastroenterology"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/bmj.284.6314.467","volume":"284","author":"MG Ashton","year":"1982","unstructured":"Ashton MG, Holdsworth CD, Ryan RP, Moore M: Healing of gastric ulcers, after one, two and three months of ranitidine. Br Med J 284:467?468, 1982","journal-title":"Br Med J"},{"key":"CR23","first-page":"80","volume-title":"Duodenal Ulcer, Gastric Ulcer, Sucralfate: A New Therapeutic Concept","author":"B Fixa","year":"1981","unstructured":"Fixa B, Komarova O: Aluminum sucrose sulphate (Sucralfate) in the treatment of peptic ulcer (double-blind study).In: WF Caspary (ed). Duodenal Ulcer, Gastric Ulcer, Sucralfate: A New Therapeutic Concept. Munich, Urban & Schwarzenberg, 1981, pp 80?84"},{"key":"CR24","series-title":"Proc Conf on Sucralfate, Symposium","first-page":"85","volume-title":"Duodenal Ulcer, Gastric Ulcer, Sucralfate: A New Therapeutic Concept","author":"R Orchard","year":"1981","unstructured":"Orchard R, Eliot C: A double-blind placebo controlled study of sucralfate in the treatment of gastric and duodenal ulcer.In: WF Caspary (ed). Duodenal Ulcer, Gastric Ulcer, Sucralfate: A New Therapeutic Concept. Munich, Urban & Schwarzenberg, 1981 pp 85?88. Proc Conf on Sucralfate, Symposium no. 11, Hamburg Germany, Int Conf on Gastroenterology"},{"key":"CR25","first-page":"101","volume-title":"Duodenal Ulcer, Gastric Ulcer, Sucralfate: A New Therapeutic Concept","author":"J Rhodes","year":"1981","unstructured":"Rhodes J, Mayberry JF, Williams RA, Lawrie BW: Chemical trials of sucralfate in the treatment of gastric ulcers.In: WF Caspary (ed). Duodenal Ulcer, Gastric Ulcer, Sucralfate: A New Therapeutic Concept. Munich, Urban & Schwarzenberg, 1981, pp 101?104"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/bmj.2.6090.795","volume":"2","author":"F Frost","year":"1977","unstructured":"Frost F, Rahbek I, Jensen KB, Gudmand-Hoyer E, Krag E, Rask-Madsen J, Wulff Hr, Garbol J, Jensen KG, Hojlung M, Nissen VR: Cimetidine in patients with gastric ulcer?a multicenter controlled trial. Br Med J 2:795, 1977","journal-title":"Br Med J"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0016-5085(78)90774-6","volume":"74","author":"E Englert Jr","year":"1978","unstructured":"Englert E Jr, Freston JW, Graham DY, Finkelstein W, Kruss DM, Priest RJ, Raskin JB, Rhodes JB, Rogers AI, Wenger J, Wilcox LL, Crossley RI: Cimetidine, antacid and hospitalization in the treatment of benign gastric ulcer. Gastroenterology 74:416?425, 1978","journal-title":"Gastroenterology"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0016-5085(77)80196-0","volume":"72","author":"U Scheurer","year":"1977","unstructured":"Scheurer U, Witzel L, Halter F, Keller HM, Huber R, Galeazzi R: Gastric and duodenal ulcer healing under placebo treatment. Gastroenterology 72:838?841, 1977","journal-title":"Gastroenterology"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0016-5085(78)90775-8","volume":"74","author":"JW Freston","year":"1978","unstructured":"Freston JW: Cimetidine in the treatment of gastric ulcer. Gastroenterology 74:426?430, 1978","journal-title":"Gastroenterology"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM197708182970701","volume":"297","author":"WL Peterson","year":"1977","unstructured":"Peterson WL, Sturdevant RAL, Frankl HD, Richardson CT, Isenberg JI, Elashoff JD, Sones JQ, Gross RA, McCallum RW, Fordtran JS: Healing of duodenal ulcer with an antacid regimen. N Engl J Med 297:341?345, 1977","journal-title":"N Engl J Med"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01309404.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01309404\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01309404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T14:19:20Z","timestamp":1586182760000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01309404"}},"subtitle":["A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1"],"short-title":[],"issued":{"date-parts":[[1985,11]]},"references-count":30,"journal-issue":{"issue":"S11","published-print":{"date-parts":[[1985,11]]}},"alternative-id":["BF01309404"],"URL":"https:\/\/doi.org\/10.1007\/bf01309404","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,11]]}}}